Coherus Biosciences | CHRS - Market Capitalization


Coherus Biosciences reported $180.1M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Akebia Therapeutics USD 312M 115M Mar/2026
ALKERMES USD 4.47B 146M Mar/2026
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Amarin USD 308M 18M Mar/2026
Amgen USD 176.25B 24.32B Dec/2025
Baxter International USD 9.82B 1.87B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
BioMarin Pharmaceutical USD 11.76B 348M Mar/2026
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Coherus Biosciences USD 183M 11M Mar/2026
Eli Lilly USD 1.02T 293.84B Dec/2025
Fujifilm JPY 3.67T 362.61B Mar/2026
Gilead Sciences USD 152.28B 14.55B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Myriad Genetics USD 417M 158M Mar/2026
Pacira USD 1.06B 94M Dec/2025
Perrigo USD 1.4B 520M Mar/2026
Pfizer USD 153.96B 12.4B Mar/2026
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025
Xencor USD 1.09B 256M Dec/2025
Zoetis USD 55.45B 9.4B Dec/2025